This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Branding Remove Clinical Development Remove Cosmetics Remove Dermatology
article thumbnail

Letybo Earns FDA Approval, Hugel Expands Its Global Aesthetic Market Leadership

XTalks

JUNE 17, 2024

This is a huge achievement for Hugel as we focus on becoming a top aesthetics brand in the US,” said James Hartman, president of Hugel America in the news release. “As While Hugel has not disclosed the price for Letybo at this time, it is estimated that similar treatments, such as Botox Cosmetic, can range from $325 to $600.

FDA Approval 52
FDA Approval Marketing Botox Clinical Trials 52
article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40
Licensing Licensing Dermatology Production 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024